Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$67.18 - $84.11 $6,718 - $8,411
-100 Reduced 50.0%
100 $8,000
Q1 2022

May 04, 2022

SELL
$66.02 - $79.71 $40,272 - $48,623
-610 Reduced 75.31%
200 $16,000
Q4 2021

Feb 10, 2022

BUY
$63.34 - $74.11 $51,305 - $60,029
810 New
810 $59,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.